Latest News

Latest News

News from the World Hepatitis Alliance

Hepatitis Testing Innovation Contest now open for submissions!

19 Jan 2016 Tara Farrell

Do you have a new and exciting idea on how to deliver hepatitis B and C testing? Be in with a chance to contribute to the 2016 WHO Hepatitis Testing...

World Hepatitis Day 2015 Summary Report released

19 Jan 2016 Bridie Taylor

On 28 July, World Hepatitis Day (WHD) brings the world together to raise awareness of the global burden of viral hepatitis and to influence real...

Public health experts, patients and policymakers convene at inaugural African Viral Hepatitis Summit to discuss the need for comprehensive national plans

19 Jan 2016 Tara Farrell

Today, more than 100 leading African and international public health experts, patient representatives, policymakers and physicians have gathered in...

Patient Solidarity Day: Uniting to declare healthcare a human right

3 Dec 2015 Bridie Taylor

On 5th December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that healthcare is a human right. Co-ordinated by...

Welcoming four new members

2 Dec 2015 Bridie Taylor

The World Hepatitis Alliance continues to grow as we welcome four new member organisations. Our membership is now made up of over 225 groups in 81...

HIV patients with viral hepatitis are three times more likely to have liver disease, liver failure and liver-related deaths

1 Dec 2015 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2015 -...

Innovative patent agreement shows success of patient advocacy

23 Nov 2015 Bridie Taylor

The World Hepatitis Alliance congratulates the Medicines Patent Pool (MPP) and Bristol – Myers Squibb (BMS) for recognising the global hepatitis...

Medicines Patent Pool expands its mandate to hepatitis C treatment

6 Nov 2015 Bridie Taylor

The World Hepatitis Alliance welcomes the recent announcement from the Medicines Patent Pool (MPP) that they will be expanding their mandate to...

The global hepatitis community unites to demand access to life-saving hepatitis treatment

2 Nov 2015 Bridie Taylor

London, 2 November 2015: Today the World Hepatitis Alliance launches an open letter calling for immediate action to vastly improve access to life-...

Webinar on the Global Movement to Eliminate Viral Hepatitis

27 Oct 2015 Bridie Taylor

Learn more about the global movement to eliminate viral hepatitis. On 28 th October WHA President Charles Gore and WHA Executive Board Member for the...

WHO Regional Committee meetings see regions commit to tackling viral hepatitis

23 Oct 2015 Bridie Taylor

Despite viral hepatitis impacting almost every country in the world, the burden differs significantly from region to region. In order to achieve...

Expanding the membership base of the World Hepatitis Alliance

1 Oct 2015 Bridie Taylor

The membership base of the World Hepatitis Alliance continues to go from strength to strength as we welcome five new organisations. Our membership is...

Looking ahead to the next Summit

17 Sep 2015 Bridie Taylor

Following the first World Hepatitis Summit that took place in Glasgow, Scotland 2-4 September, we are already looking ahead to the next Summit. The...

Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025

15 Sep 2015

By Keith Alcorn, Infohep.org Reaching the World Health Organization’s proposed targets for viral hepatitis control by 2030 could require global...

Medicines Patent Pool looks at hepatitis C

14 Sep 2015

By Keith Alcorn, Infohep.org Greg Perry, Executive Director of the Medicines Patent Pool, told delegates at the World Hepatitis Summit in Glasgow...

World Health Organization calls for ambitious global targets for viral hepatitis control

5 Sep 2015

By Keith Alcorn, Infohep.org The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of...

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit

4 Sep 2015 Bridie Taylor

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit Global leaders...

World Hepatitis Summit: New data shows relentless rise in hepatitis deaths

2 Sep 2015

New data shows relentless rise in hepatitis deaths: World leaders meet in Scotland to discuss urgent response and move towards elimination of 7th...

Is the elimination of viral hepatitis on the horizon?

28 Jul 2015 Bridie Taylor

Today marks the fifth official World Hepatitis Day where members of the public and the hepatitis community provide a voice for the 4000 lives lost...

Welcoming new members to the World Hepatitis Alliance

17 Jul 2015 Bridie Taylor

Over the past few months we have welcomed a surge of new members to the World Hepatitis Alliance and we are proud to now have 216 member groups in 80...

Pages

News from infohep

Will people with liver disease be prioritised for COVID-19 vaccination?

19 Jan 2021 Keith Alcorn
People with decompensated cirrhosis should be prioritised for COVID-19 vaccination and immunosuppressive treatment after a liver transplant should...

What's needed to eliminate hepatitis C in people with HIV in Scotland?

18 Jan 2021 Keith Alcorn
To eliminate hepatitis C in people with HIV in Scotland, healthcare providers will need to reach people not on HIV treatment and step up testing...

Public-sector hepatitis C treatment programmes expanding in lower- and middle-income countries

8 Jan 2021 Keith Alcorn
Public-sector hepatitis C treatment programmes have cured tens of thousands of people in lower- and lower-middle-income countries with the aid of low...

Semaglutide alone or in combination regimens shows promise for NASH

18 Dec 2020 Liz Highleyman
Semaglutide, a medication approved to treat type 2 diabetes, increased the likelihood of improvement in non-alcoholic steatohepatitis (NASH) without...

Lanifibranor improves NASH in 24-week trial

18 Dec 2020 Keith Alcorn
Twenty-four weeks of treatment with lanifibranor, a drug designed to treat NASH, improved liver fibrosis in 42% of people treated in a phase 2b...

Efruxifermin improves liver fat and fibrosis in people with NASH

15 Dec 2020 Keith Alcorn
Efruxifermin reduced liver fat and improved liver inflammation and fibrosis in the majority of people with NASH who received it in a phase 2a trial...

High hepatitis C cure rate achieved in New York prisons

9 Dec 2020 Keith Alcorn
Hepatitis C treatment in prisons can result in a high cure rate but people released from prison during treatment are less likely to be cured due to...

2.5 million people in Africa need urgent hepatitis B treatment

9 Dec 2020 Keith Alcorn
Around 2.5 million people with hepatitis B in sub-Saharan Africa already have cirrhosis and need immediate antiviral treatment, a systematic review...

Few countries will meet 2020 target for reducing viral hepatitis deaths

24 Nov 2020 Keith Alcorn
Around 1.1 million deaths were caused by viral hepatitis worldwide in 2019 and deaths due to hepatitis C are still rising despite the availability of...

Some hepatitis B patients can safely stop antivirals

24 Nov 2020 Liz Highleyman
Many people who take nucleoside/nucleotide antivirals for chronic hepatitis B can safely discontinue treatment, although this usually does not lead...